ISU Abxis Co., Ltd.
Develops antibody-based immunotherapies for oncology and rare diseases.
086890 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086890001
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 대왕판교로712번길 22, 씨동 5층 (삼평동, 글로벌알앤디센터), 성남시
- Sector:
- Manufacturing
Description
ISU Abxis is a biopharmaceutical company specializing in the research and development of innovative biomedicines, primarily engineered antibody-based immunotherapies. Founded in 2001, the company leverages genetic recombination technology to create novel treatments. Its pipeline is focused on addressing significant unmet medical needs in oncology and rare diseases. Key development programs include therapeutics for cancers like Head and Neck Squamous Cell Carcinoma (ISU104) and treatments for rare genetic disorders such as Fabry disease (Fabagal). The company is dedicated to developing advanced antibody-based therapeutics to improve the quality of life for patients with difficult-to-treat conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-17 00:00 |
[기재정정]주주총회소집공고
|
Korean | 93.2 KB | ||
| 2022-03-17 00:00 |
감사보고서제출
|
Korean | 17.0 KB | ||
| 2022-03-17 00:00 |
사업보고서 (2021.12)
|
Korean | 395.2 KB | ||
| 2022-03-03 00:00 |
주주총회소집결의
|
Korean | 11.4 KB | ||
| 2022-03-03 00:00 |
주주총회소집공고
|
Korean | 89.8 KB | ||
| 2022-03-03 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.2 KB | ||
| 2022-02-10 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.0 KB | ||
| 2022-01-26 00:00 |
투자판단관련주요경영사항(희귀질환 치료제 '파바갈(Fabagal)' 기술이전 계약 체결)
|
Korean | 10.8 KB | ||
| 2022-01-26 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 91.1 KB | ||
| 2022-01-05 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2022-01-05 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 90.3 KB | ||
| 2021-12-30 00:00 |
전환가액의조정
|
Korean | 10.7 KB | ||
| 2021-12-27 00:00 |
대표이사변경
|
Korean | 11.6 KB | ||
| 2021-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2021-11-23 00:00 |
기타경영사항(특허권취득)(자율공시)(ErbB3에 특이적으로 결합하는 항체 및 그의 용도)
|
Korean | 4.9 KB |
Automate Your Workflow. Get a real-time feed of all ISU Abxis Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ISU Abxis Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ISU Abxis Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
